SCHEMBL723659

SCHEMBL723659

C=CCC=CCC=CCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
CYP19A1 P11511 4/20 0.41
PPARG P37231 3/20 0.41
OXER1 Q8TDS5 3/20 0.41
MAPT P10636 3/20 0.41
RXRA P19793 2/20 0.41
FFAR1 O14842 2/20 0.41
F7 P08709 3/20 0.38
F3 P13726 3/20 0.38
PPARA Q07869 3/20 0.38
PTGS1 P23219 3/20 0.38
KMT2A Q03164 2/20 0.38
PPARD Q03181 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
NR1I2 O75469 2/20 0.35
PTGS2 P35354 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
PLA2G1B P04054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15483912 1.00 ALDH1A1 (0.41) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL723658 1.00 ALDH1A1 (0.41) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL16802807 1.00 ALDH1A1 (0.41) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL403912 0.97
SCHEMBL124127 0.97
SCHEMBL6480691 0.97
SCHEMBL3949352 0.88 ALDH1A1 (0.43) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL3949348 0.88 ALDH1A1 (0.43) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL28953458 0.85 ALDH1A1 (0.55) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL25171261 0.84 ALDH1A1 (0.47) ALDH1A1CYP19A1PPARGOXER1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8557902-B2 Functionalizable synthetic hydrocarbon fluids and integrated method for production thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-10-15 US claimed
US-20120053309-A1 Functionalizable Synthetic Hydrocarbon Fluids and Integrated Method for Production Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2012-03-01 US claimed
JP-55104218-A None JP disclosed
US-12145906-B2 Renewable chemical production engaging metathesis and microbial oxidation NESTE OYJ (FI) 2024-11-19 US disclosed
US-20230339828-A2 RENEWABLE CHEMICAL PRODUCTION ENGAGING METATHESIS AND MICROBIAL OXIDATION NESTE OYJ (FI) 2023-10-26 US disclosed
US-11795124-B2 Renewable alkene production engaging metathesis NESTE OYJ (FI) 2023-10-24 US disclosed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
US-11643616-B2 Renewable base oil production engaging metathesis NESTE OYJ (FI) 2023-05-09 US disclosed
US-20220363613-A1 RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS NESTE OYJ (FI) 2022-11-17 US disclosed
US-20220356131-A1 RENEWABLE CHEMICAL PRODUCTION ENGAGING METATHESIS AND MICROBIAL OXIDATION NESTE OYJ (FI) 2022-11-10 US disclosed
US-20220340835-A1 RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS NESTE OYJ (FI) 2022-10-27 US disclosed
WO-2012112828-A1 BIO-BASED LINEAR ALKYLPHENYL SULFONATES THE PROCTER & GAMBLE COMPANY (US) 2012-08-23 WO disclosed
US-20120213726-A1 BIO-BASED LINEAR ALKYLPHENYL SULFONATES THE PROCTER & GAMBLE COMPANY 2012-08-23 US disclosed
US-20120214724-A1 Mixtures OF C10-C13 Alkylphenyl Sulfonates THE PROCTER & GAMBLE COMPANY 2012-08-23 US disclosed
US-20120101290-A1 METHOD FOR PRODUCING RUTHENIUM COMPOUND TRI CHEMICAL LABORATORIES, INC. (JP) 2012-04-26 US disclosed
US-20120053309-A1 Functionalizable Synthetic Hydrocarbon Fluids and Integrated Method for Production Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2012-03-01 US disclosed
WO-2012027139-A2 FUNCTIONALIZABLE SYNTHETIC HYDROCARBON FLUIDS AND INTEGRATED METHOD OF FOR PRODUCTION THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2012-03-01 WO disclosed
US-4570025-A HYDROGENATION IN THE PRESENCE OF PALLADIUM METAL ON AN ALUMINUM PHOSPHATE SUPPORT CATALYST PHILLIPS PETROLEUM COMPANY (US) 1986-02-11 US disclosed
US-4287378-A BY CATALYTIC DISPROPORTIONATION, PROPORTIONATION, OR ISOMERIZATION WHEREIN THE CATALYST IS A TRANSITION METAL OXIDE EXPOSED TO RADIATION PHILLIPS PETROLEUM COMPANY (US) 1981-09-01 US disclosed
JP-S55104218-A PRODUCTION OF 1,6,8-DECATRIENE SUMITOMO CHEM CO LTD 1980-08-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339828-A2 RENEWABLE CHEMICAL PRODUCTION ENGAGING METATHESIS AND MICROBIAL OXIDATION FASN, COASY, MLYCD ALDH1A1 75/4885CYP19A1 371/4885PPARG 2115/4885
US-12145906-B2 Renewable chemical production engaging metathesis and microbial oxidation FASN, MLYCD, COASY ALDH1A1 85/4885CYP19A1 325/4885PPARG 2079/4885
US-20220340835-A1 RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS FASN, DGAT2, GK ALDH1A1 626/4885CYP19A1 734/4885PPARG 252/4885
US-20120213726-A1 BIO-BASED LINEAR ALKYLPHENYL SULFONATES PSAP, CUTA, AGPS ALDH1A1 475/4885CYP19A1 2158/4885PPARG 2270/4885
US-20220363613-A1 RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS FASN, DGAT2, DGAT1 ALDH1A1 202/4885CYP19A1 608/4885PPARG 572/4885
US-20120214724-A1 Mixtures OF C10-C13 Alkylphenyl Sulfonates SMURF1, C1S, SMURF2 ALDH1A1 981/4885CYP19A1 2180/4885PPARG 2489/4885
US-20220356131-A1 RENEWABLE CHEMICAL PRODUCTION ENGAGING METATHESIS AND MICROBIAL OXIDATION FASN, MLYCD, COASY ALDH1A1 85/4885CYP19A1 325/4885PPARG 2079/4885
US-11643616-B2 Renewable base oil production engaging metathesis FASN, DGAT2, GK ALDH1A1 626/4885CYP19A1 734/4885PPARG 252/4885
US-11795124-B2 Renewable alkene production engaging metathesis FASN, DGAT2, DGAT1 ALDH1A1 202/4885CYP19A1 608/4885PPARG 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.